Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Next-Generation Sequencing in Medicine (Upcoming)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Adenylyl cyclase 5–generated cAMP controls cerebral vascular reactivity during diabetic hyperglycemia
Arsalan U. Syed, … , Madeline Nieves-Cintrón, Manuel F. Navedo
Arsalan U. Syed, … , Madeline Nieves-Cintrón, Manuel F. Navedo
Published June 4, 2019
Citation Information: J Clin Invest. 2019;129(8):3140-3152. https://doi.org/10.1172/JCI124705.
View: Text | PDF
Research Article Cell biology Vascular biology

Adenylyl cyclase 5–generated cAMP controls cerebral vascular reactivity during diabetic hyperglycemia

  • Text
  • PDF
Abstract

Elevated blood glucose (hyperglycemia) is a hallmark metabolic abnormality in diabetes. Hyperglycemia is associated with protein kinase A–dependent (PKA-dependent) stimulation of L-type Ca2+ channels in arterial myocytes resulting in increased vasoconstriction. However, the mechanisms by which glucose activates PKA remain unclear. Here, we showed that elevating extracellular glucose stimulates cAMP production in arterial myocytes, and that this was specifically dependent on adenylyl cyclase 5 (AC5) activity. Super-resolution imaging suggested nanometer proximity between subpopulations of AC5 and the L-type Ca2+ channel pore-forming subunit CaV1.2. In vitro, in silico, ex vivo, and in vivo experiments revealed that this close association is critical for stimulation of L-type Ca2+ channels in arterial myocytes and increased myogenic tone upon acute hyperglycemia. This pathway supported the increase in L-type Ca2+ channel activity and myogenic tone in 2 animal models of diabetes. Our collective findings demonstrate a unique role for AC5 in PKA-dependent modulation of L-type Ca2+ channel activity and vascular reactivity during acute hyperglycemia and diabetes.

Authors

Arsalan U. Syed, Gopireddy R. Reddy, Debapriya Ghosh, Maria Paz Prada, Matthew A. Nystoriak, Stefano Morotti, Eleonora Grandi, Padmini Sirish, Nipavan Chiamvimonvat, Johannes W. Hell, Luis F. Santana, Yang K. Xiang, Madeline Nieves-Cintrón, Manuel F. Navedo

×

Figure 2

AC activity is required for vascular L-type Ca2+ channel potentiation and vasoconstriction in response to increased glucose.

Options: View larger image (or click on image) Download as PowerPoint
AC activity is required for vascular L-type Ca2+ channel potentiation an...
(A and B) Exemplary nifedipine-sensitive IBa from WT arterial myocytes untreated (A) and pretreated with 2,5-DDA (B) in response to a voltage ramp before and after increasing of extracellular glucose from 10 mM to 20 mM. (C) Representative IBa traces showing changes in glucose-induced current during a ramp depolarization from –80 mV to +40 mV in 2,5-DDA–untreated (–) (black trace) and 2,5-DDA–treated (+) (green trace) cells. (D) Plot (mean ± SEM) of the integrated area under the curve (pA∙ms) of nifedipine-sensitive IBa recorded in response to a voltage ramp before and after increasing of extracellular glucose from 10 mM to 20 mM in –2,5-DDA and +2,5-DDA arterial myocytes (n = 8 cells from 5 mice for the –2,5-DDA group and n = 7 cells from 3 mice for the +2,5-DDA group). *P < 0.05, Wilcoxon matched-pairs signed-rank test. Significance was compared between 10 mM and 20 mM d-glucose for each data set. Cell capacitance was similar for the –2,5-DDA (14 ± 0.5 pF) and +2,5-DDA data sets (15.7 ± 1.5 pF; P = 0.5100, Mann-Whitney test). (E–G) Representative diameter recordings (E and F) and summary plot of changes in arterial tone (G) from pressurized (60 mmHg) WT arteries untreated (n = 6 arteries from 6 mice) and pretreated (n = 6 arteries from 4 mice) with 2,5-DDA in response to 20 mM d-glucose. *P < 0.05, Mann-Whitney test. Data represent mean ± SEM.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts